Diagnosis and treatment of esthesioneuroblastoma

Abstract

Li Guangxin, Shu Xin, Li Gong, Gou Miaomiao. Diagnosis and treatment of esthesioneuroblastoma[J]. Journal of International Oncology, 2014, 41(5): 338-341.

［1］ Aggarwal SK, Kumar R, Shrivastav A, et al. Esthesioneuroblastoma presenting with proptosis and bilateral neck metastasis: an unusual presentation［J］. J Pediatr Neurosci, 2011, 6(1):78-81. ［2］ Bisogno G, Soloni P, Conte M, et al. Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees［J］. BMC Cancer, 2012, 12:117. ［3］ Majchrzak E, Wegner A, Golusiński W. Diagnostic difficulties of the patient with sinonasal tract tumor; therapeutic dilemmasa case report and up to date review ［J］. Otolaryngol Pol, 2011, 65(5):377-382. ［4］ Gallia GL, Reh DD, Lane AP, et al. Endoscopic resection of esthesioneuroblastoma ［J］. J Clin Neurosci, 2012, 19(11):1478-1482. ［5］ Ward PD, Heth JA, Thompson BG, et al. Esthesioneuroblastoma: results and outcomes of a single institution′s experience［J］. Skull Base, 2010, 19(2):133-140. ［6］ Kane AJ, Sughrue ME, Rutkowski MJ, et al. Posttreatment prognosis of patients with esthesioneuroblastoma［J］. J Neurosurg, 2010, 113(2):340-351. ［7］ Hanna E, DeMonte F, Ibrahim S, et al. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results［J］. Arch Otolaryngol Head Neck Surg, 2009, 135(12):1219-1224. ［8］ Damar M, Baserer N, Ozkara S, et al. Late neck metastasis in esthesioneuroblastoma: a case report［J］. Kulak Burun Boqaz Ihtis Derg, 2012, 22(4):228-231. ［9］ Devaiah AK, Andreoli MT. Treatment of esthesioneuroblastoma: a 16year metaanalysis of 361 patients［J］. Laryngoscope, 2009, 119(7):1412-1416. ［10］ Bak M, Wein RO. Esthesioneuroblastoma: a contemporary review of diagnosis and management［J］. Hematol Oncol Clin Norht Am, 2012, 26(6):1185-1207. ［11］ Hojo H, Zenda S, Akimoto T, et al. Impact of early radiological response evaluation on radiotherapeutic outcomes in the patients with nasal cavity and paranasal sinus malignancies［J］. J Radiat Res, 2012, 53(5):704-709. ［12］ Nichols AC, Chan AW, Curry WT, et al. Esthesioneuroblastoma: the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy［J］. Skull Base, 2008, 18(5):327-337. ［13］ Bachar G, Goldstein DP, Shah M, et al. Esthesioneuroblastoma: the princess margaret hospital experience［J］. Head Neck, 2008, 30(12):1607-1614. ［14］ Jiang GY, Li FC, Chen WK, et al. Therapy and prognosis of intracranial invasive olfactory neuroblastoma［J］. Otolaryngol Head Neck Srug, 2011, 145(6):951-955. ［15］ Platek ME, Merzianu M, Mashtare TL, et al. Improved sruvival following srugery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database［J］. Radiat Oncol, 2011, 6:41. ［16］ Ozsahin M, Gruber G, Olszyk O, et al. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study［J］. Int J Radiat Oncol Biol Phys, 2010, 78(4):992-997. ［17］ Gupta S, Husain N, Sundar S. Esthesioneuroblastoma chemotherapy and radiotherapy for extensive disease: a case report［J］. World J Surg Oncol, 2011, 9:118.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[3]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[4]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[5]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[6]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[7]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[8]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[9]	Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy[J]. Journal of International Oncology, 2024, 51(5): 257-266.
[10]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[11]	Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor[J]. Journal of International Oncology, 2024, 51(5): 298-302.
[12]	Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.Progress of ferroptosis-related mechanisms in osteosarcoma[J]. Journal of International Oncology, 2024, 51(5): 308-311.
[13]	Yang Hao, Shi Guidong, Zhang Chengcheng, Zhang Yue, Zhang Liwen, Fu Maoyong.Comparison of efficacy and safety between sintilimab and tislelizumab in neoadjuvant therapy for advanced esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(4): 210-216.
[14]	Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234.
[15]	Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238.

Diagnosis and treatment of esthesioneuroblastoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments